2-iodomelatonin has been researched along with vasoactive intestinal peptide in 2 studies
| Studies (2-iodomelatonin) | Trials (2-iodomelatonin) | Recent Studies (post-2010) (2-iodomelatonin) | Studies (vasoactive intestinal peptide) | Trials (vasoactive intestinal peptide) | Recent Studies (post-2010) (vasoactive intestinal peptide) |
|---|---|---|---|---|---|
| 245 | 0 | 10 | 10,873 | 123 | 1,221 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calvo, JR; Guerrero, JM; Lopez-Gonzalez, MA; Osuna, C; Rubio, A | 1 |
| Calvo, JR; Guerrero, JM; Lopez-Gonzalez, MA; Osuna, C | 1 |
2 other study(ies) available for 2-iodomelatonin and vasoactive intestinal peptide
| Article | Year |
|---|---|
Melatonin potentiates cyclic AMP production stimulated by vasoactive intestinal peptide in human lymphocytes.
Topics: Cyclic AMP; Humans; In Vitro Techniques; Lymphocytes; Melatonin; Vasoactive Intestinal Peptide | 1992 |
Interaction of melatonin with human lymphocytes: evidence for binding sites coupled to potentiation of cyclic AMP stimulated by vasoactive intestinal peptide and activation of cyclic GMP.
Topics: Binding, Competitive; Cell Membrane; Cyclic AMP; Cyclic GMP; Drug Synergism; Humans; Lymphocytes; Melatonin; Purine Nucleotides; Pyrimidine Nucleotides; Receptors, Melatonin; Receptors, Neurotransmitter; Vasoactive Intestinal Peptide | 1992 |